Clinical Trial Update: Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy [NA]

View source ↗

Summary

This clinical trial update states that iptacopan is being studied for high-risk transplantation-associated thrombotic microangiopathy and the study is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thrombotic Microangiopathy

Drugs mentioned

• iptacopan (iptacopan)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Thrombotic Microangiopathy, Hematopoietic Stem Cell Transplantation (HSCT) | NA | Status: NOT_YET_RECRUITING